{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:14:36Z","timestamp":1791983676656,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Action Arthritis","award":["R20459"],"award-info":[{"award-number":["R20459"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1127-3","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:04:46Z","timestamp":1468533886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-8920","authenticated-orcid":false,"given":"Max","family":"Yates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Arthur","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander James","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"issue":"11","key":"1127_CR1","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/jnnp.2006.113787","volume":"78","author":"T Loddenkemper","year":"2007","unstructured":"Loddenkemper T, Sharma P, Katzan I, Plant GT. Risk factors for early visual deterioration in temporal arteritis. J Neurol Neurosurg Psychiatry. 2007;78(11):1255\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1127_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11882-008-0052-4","volume":"8","author":"F Borg","year":"2008","unstructured":"Borg F, Salter VJ, Dasgupta B. Neuro-ophthalmic complications in giant cell arteritis. Curr Allergy Asthma Rep. 2008;8(4):323\u201330.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1127_CR3","volume-title":"Senile Rheumatic Gout","author":"W Bruce","year":"1888","unstructured":"Bruce W. Senile Rheumatic Gout. 1888."},{"issue":"2","key":"1127_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.16.2.230","volume":"16","author":"HS Barber","year":"1957","unstructured":"Barber HS. Myalgic syndrome with constitutional effects; polymyalgia rheumatica. Ann Rheum Dis. 1957;16(2):230\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6492","key":"1127_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/bmj.291.6492.385","volume":"291","author":"V Kyle","year":"1985","unstructured":"Kyle V, Silverman B, Silman A, King H, Oswald N, Reiss B, et al. Polymyalgia rheumatica\/giant cell arteritis in a Cambridge general practice. Br Med J. 1985;291(6492):385\u20137.","journal-title":"Br Med J"},{"key":"1127_CR6","doi-asserted-by":"crossref","unstructured":"Petri H, Nevitt A, Sarsour K, Napalkov P, Collinson N. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Arthritis Care Res (Hoboken). 2014.","DOI":"10.1002\/acr.22429"},{"issue":"1","key":"1127_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis & Rheumatism. 2008;58(1):26\u201335.","journal-title":"Arthritis & Rheumatism"},{"issue":"3","key":"1127_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.1780380311","volume":"38","author":"C Salvarani","year":"1995","unstructured":"Salvarani C, Gabriel SE, O\u2019Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970\u20131991. Arthritis Rheum. 1995;38(3):369\u201373.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1127_CR9","first-page":"1694","volume":"29","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, O\u2019Fallon WM, Hunder GG, Gabriel SE. Trends in the incidence of polymyalgia rheumatica over a 30\u00a0year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002;29(8):1694\u20137.","journal-title":"J Rheumatol"},{"issue":"5","key":"1127_CR10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","volume":"53","author":"K Herlyn","year":"2014","unstructured":"Herlyn K, Buckert F, Gross WL, Reinhold-keller E. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (United Kingdom). 2014;53(5):882\u20139.","journal-title":"Rheumatology (United Kingdom)"},{"issue":"8","key":"1127_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The american college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis & Rheumatism. 1990;33(8):1122\u20138 [Research Support, U.S. Gov\u2019t, P.H.S.].","journal-title":"Arthritis & Rheumatism"},{"issue":"5","key":"1127_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38(5):434\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1127_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"TY Chuang","year":"1982","unstructured":"Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1127_CR14","first-page":"64","volume":"141","author":"LA Healey","year":"1984","unstructured":"Healey LA, Wilske KR. Polymyalgia rheumatica and giant cell arteritis. West J Med. 1984;141(1):64\u20137.","journal-title":"West J Med"},{"issue":"1","key":"1127_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ard.40.1.1","volume":"40","author":"JG Jones","year":"1981","unstructured":"Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981;40(1):1\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1127_CR16","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/annrheumdis-2013-204167","volume":"73","author":"P Macchioni","year":"2014","unstructured":"Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR\/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis. 2014;73(6):1190\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1127_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71(4):484\u201392.","journal-title":"Ann Rheum Dis"},{"issue":"610","key":"1127_CR18","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.3399\/bjgp13X667231","volume":"63","author":"T Helliwell","year":"2013","unstructured":"Helliwell T, Hider SL, Mallen CD. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract. 2013;63(610):e361\u20136.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"1127_CR19","first-page":"830","volume":"27","author":"ON Pamuk","year":"2009","unstructured":"Pamuk ON, Donmez S, Karahan B, Pamuk GE, Cakir N. Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: clinical features and epidemiological data. Clin Exp Rheumatol. 2009;27(5):830\u20133.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1127_CR20","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/art.11195","volume":"49","author":"S Kobayashi","year":"2003","unstructured":"Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49(4):594\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1127_CR21","first-page":"1","volume":"63","author":"A Mohammad","year":"2011","unstructured":"Mohammad A, Mohammad J, Nilsson JA, Jacobsson LTH, Merkel PA, Turesson C. Incidence, prevalence, and mortality rates of biopsy-proven giant cell arteritis in Southern Sweden. Arthritis Rheum. 2011;63(1):1.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1127_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/ard.2005.046912","volume":"65","author":"L Smeeth","year":"2006","unstructured":"Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis [Research Support, Non-US Gov\u2019t]. 2006;65(8):1093\u20138.","journal-title":"Ann Rheum Dis [Research Support, Non-US Gov\u2019t]"},{"issue":"9","key":"1127_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/art.24793","volume":"61","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Joseph L, Pineau CA, Belisle P, Lix L, Banerjee D, et al. Polymyalgia rheumatica prevalence in a population-based sample. Arthritis Care Res. 2009;61(9):1264\u20137.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"1127_CR24","first-page":"819","volume":"23","author":"F Salaffi","year":"2005","unstructured":"Salaffi F, De Angelis R, Grassi W. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23(6):819\u201328.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1127_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund B, Helleberg M, Faurschou M, Obel N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford). 2015;54(1):139\u201343.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1127_CR26","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.3899\/jrheum.101254","volume":"38","author":"J Ninan","year":"2011","unstructured":"Ninan J, Nguyen AM, Cole A, Rischmueller M, Dodd T, Roberts-Thomson P, et al. Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study. J Rheumatol. 2011;38(10):2215\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"1127_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/rheumatology\/33.8.735","volume":"33","author":"DP Symmons","year":"1994","unstructured":"Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol. 1994;33(8):735\u20139.","journal-title":"Br J Rheumatol"},{"issue":"2","key":"1127_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","volume":"43","author":"RA Watts","year":"2000","unstructured":"Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43(2):414\u20139.","journal-title":"Arthritis Rheum"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1127-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1127-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1127-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T01:24:30Z","timestamp":1568165070000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1127-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1127-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,15]]},"article-number":"285"}}